Baxter Issues Voluntary Nationwide Recall for Two Lots of 0.9% Sodium Chloride Injection Due to Potential Presence of Particulate Matter
- Date
- Aug 25, 2026
- Company
- Baxter International Inc.
- Brand
- Baxter
- Product
- 0.9% Sodium Chloride Injection, USP, 500 mL VIAFLEX Plastic Container
- Reason
- Potential presence of particulate matter identified as fiberglass in the solution.
- Hazard
- Other
- Source
- FDA
How to identify the product
- The affected lots can be identified by locating the lot number and expiration date on the individual product and shipping carton, as shown in the images below.
- The impacted product was distributed from 7/31/2026 to 8/3/2026 to healthcare providers and distributors to select states in the United States, including Florida, Illinois, Indiana, Louisiana, Maryland, Missouri, North Carolina, New Jersey, Nevada, New York, Ohio, South Carolina, Texas, and Virginia.
- Customers should immediately discontinue use of and return all affected units in accordance with their facility’s process.
- Baxter is contacting customers by email with instructions on how to identify and return the impacted product.
Product photos are on the official FDA page.
Facts are taken from the official notice. If anything here differs from it, the official notice is correct.